Related Experiment Video
Updated: Feb 9, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Mycoplasma pneumoniae: A Potentially Severe Infection
Bharat Bajantri1, Sindhaghatta Venkatram1, Gilda Diaz-Fuentes1
1Division of Pulmonary Critical Care, Department of Medicine, Bronx Care Health System, Bronx, NY 10457, USA.
Mycoplasma pneumoniae causes common community-acquired pneumonia (CAP) with diverse symptoms, making diagnosis difficult. Emerging macrolide resistance and travel complicate treatment and control of this infection.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Background:
- Mycoplasma pneumoniae is a leading cause of community-acquired pneumonia (CAP).
- Clinical presentations are highly variable, affecting multiple organ systems.
- Diagnosis is often challenging due to non-specific findings and limited diagnostic tools.
Purpose of the Study:
- To provide a concise and current review of Mycoplasma pneumoniae pneumonia.
- To highlight diagnostic challenges and potential complications.
Main Methods:
- This study is a review of existing literature on Mycoplasma pneumoniae pneumonia.
- It synthesizes current knowledge on epidemiology, clinical features, diagnosis, and treatment.
Main Results:
- Mycoplasma pneumoniae pneumonia presents with a wide range of symptoms, complicating diagnosis.
- Extrapulmonary and severe pulmonary manifestations can result in long-term health issues.
- Macrolide resistance and global travel present significant challenges for infection control.
Conclusions:
- Accurate and timely diagnosis of Mycoplasma pneumoniae pneumonia remains difficult.
- Increasing antibiotic resistance and global travel necessitate updated management strategies.
- Further research is needed to address treatment and control difficulties.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

